Sherpa RX employs cutting-edge AI to revolutionize how medications are prescribed and managed. By leveraging genetic insights, we aim to ensure that every patient receives the safest and most effective treatment tailored to their specific needs.
Sherpa RX not only aids in clinical decision-making but also equips healthcare providers with tools that enhance their practice. Our platform effectively resolves the majority of routine inquiries, allowing healthcare professionals to concentrate on critical care aspects. This support ensures that each treatment is perfectly tailored to the patient’s needs, fostering better health outcomes.
Discover how Sherpa RX can elevate your clinical decisions with AI-powered precision. Our solutions provide the insights you need to deliver personalized care and optimize outcomes for every patient.
Jeff McCormack, Founder & CEO
At Sherpa RX, we are currently applying our tailored solutions to a variety of medical conditions. While these are our areas of focus today, our adaptable platform is poised to address an even broader spectrum of medical needs in the future.
We guide the selection of antidepressants and antipsychotics based on CYP2D6 and CYP2C19 genotypes, enhancing treatment responsiveness and reducing side effects.
Optimizing anticoagulant and antiplatelet therapy using genetic markers like VKORC1 and CYP2C19 to prevent complications.
Personalizing chemotherapy dosing using genetic information such as DPYD and UGT1A1 to minimize toxicity and improve outcomes.
Tailoring opioid prescriptions based on CYP2D6 metabolism status to balance efficacy with safety.
Adjusting treatments for HIV and HCV with considerations for genetic variants like HLA-B*57:01 and IFNL3, targeting effective responses.
Customizing immunosuppressant dosing using genetic insights from TPMT and CYP3A5 to enhance transplant success.
Guiding anticonvulsant therapy with genetic data, such as HLA-B*15:02, to prevent adverse reactions and improve control.
Optimizing treatments for inflammatory bowel diseases with genetic testing for TPMT and NUDT15, enhancing therapeutic efficacy.
Using genetic insights into CYP450 enzyme variants to predict drug metabolism rates and potential interactions, ensuring optimal dosing.
Sherpa RX is actively enhancing its platform by integrating a vast array of data sets to elevate our AI-driven recommendations:
CPIC Guidelines: We utilize genetic test results to optimize drug therapies, drawing on data from 34 unique genes and 164 unique drugs.
PharmGKB (currently in development): We are expanding access to clinical guidelines, drug label annotations, and FDA drug label data to further refine treatment plans.
Personalized DNA Testing: We are advancing our capabilities in DNA testing, which ensure even more precise drug selection and dosing.
Sherpa rx
Copyright © 2024 Sherpa rx - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.